Literature DB >> 26743785

[OCT angiography for exudative age-related macular degeneration : Initial experiences].

A Lommatzsch1, M-L Farecki2, B Book2, B Heimes2, D Pauleikhoff2.   

Abstract

The new technique of optical coherence tomography (OCT) angiography allows a non-invasive reconstruction of the three-dimensional structure of the total retinal and choroidal vascularization within seconds. There are still limitations caused by movement artefacts, superimposition of superficial retinal vessels at the retinal pigment epithelium (RPE) level and insufficient three-dimensional imaging modalities. Initial experiences with this new method and especially the correlation with the current standard diagnostic procedure of fluorescein angiography show that new information can be obtained regarding specific vascular and neovascular changes. For three-dimensional neovascular changes, such as those found in exudative age-related macular degeneration (AMD,) a more sophisticated diagnostic analysis strategy must be specifically developed. Initial experiences demonstrate that the differentiation into the various types of choroidal neovascularization (CNV) by fluorescein angiography, specifically for type 1 (occult) and type 2 (classical) can also be visualized by OCT angiography. Furthermore, the new technology provides additional information on the choroidal and outer retinal changes associated with this disease, which may result in a better understanding of the underlying pathology.

Entities:  

Keywords:  Artefacts; Choroid; Choroidal neovascularization; Fluorescence angiography; Retina

Mesh:

Year:  2016        PMID: 26743785     DOI: 10.1007/s00347-015-0215-3

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  14 in total

1.  High-resolution optical coherence tomography of subpigment epithelial structures in patients with pigment epithelium detachment secondary to age-related macular degeneration.

Authors:  Christoph R Clemens; Tim U Krohne; Peter Charbel Issa; Hans-Martin Helb; Nina Kosanetzky; Albrecht Lommatzsch; Frank G Holz; Nicole Eter
Journal:  Br J Ophthalmol       Date:  2012-06-13       Impact factor: 4.638

Review 2.  Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.

Authors: 
Journal:  Retina       Date:  2002-02       Impact factor: 4.256

3.  Serous retinal pigment epithelial detachment with a notch. A sign of occult choroidal neovascularization.

Authors:  J D Gass
Journal:  Retina       Date:  1984 Fall-Winter       Impact factor: 4.256

Review 4.  Retinal pigment epithelial detachments in the elderly.

Authors:  A C Bird; J Marshall
Journal:  Trans Ophthalmol Soc U K       Date:  1986

5.  Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

Authors:  Luna Xu; Sarah Mrejen; Jesse J Jung; Roberto Gallego-Pinazo; Desmond Thompson; Marcela Marsiglia; K Bailey Freund
Journal:  Retina       Date:  2015-02       Impact factor: 4.256

6.  Ultrahigh-speed swept-source OCT angiography in exudative AMD.

Authors:  Eric Moult; WooJhon Choi; Nadia K Waheed; Mehreen Adhi; ByungKun Lee; Chen D Lu; Vijaysekhar Jayaraman; Benjamin Potsaid; Philip J Rosenfeld; Jay S Duker; James G Fujimoto
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2014 Nov-Dec       Impact factor: 1.300

7.  Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization.

Authors:  Richard F Spaide
Journal:  Am J Ophthalmol       Date:  2015-04-14       Impact factor: 5.258

8.  [Serous vascularized pigment epithelial detachment in exudative AMD. Morphological typing and risk of tears in the RPE].

Authors:  B Lehmann; B Heimes; M Gutfleisch; G Spital; D Pauleikhoff; A Lommatzsch
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

9.  Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial.

Authors:  Usha Chakravarthy; Simon P Harding; Chris A Rogers; Susan M Downes; Andrew J Lotery; Lucy A Culliford; Barnaby C Reeves
Journal:  Lancet       Date:  2013-07-19       Impact factor: 79.321

10.  Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.

Authors:  Usha Chakravarthy; Simon P Harding; Chris A Rogers; Susan M Downes; Andrew J Lotery; Sarah Wordsworth; Barnaby C Reeves
Journal:  Ophthalmology       Date:  2012-05-11       Impact factor: 12.079

View more
  2 in total

1.  [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG): OCT angiography in Germany : Presentation, nomenclature and future plans. Situation January 2017].

Authors: 
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

2.  [Choroidal neovascularisation in a patient with choroidal osteoma visualized by OCT angiography].

Authors:  N Mihailovic; M Alnawaiseh; R-L Merté; N Eter
Journal:  Ophthalmologe       Date:  2017-09       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.